Literature DB >> 17211456

Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism.

K F Nilsson1, L E Gustafsson, L C Adding, D Linnarsson, P Agvald.   

Abstract

BACKGROUND AND
PURPOSE: Pulmonary embolism (PE) represents a real diagnostic challenge. PE is associated with pulmonary hypertension due to pulmonary vascular obstruction and vasoconstriction. We recently reported that pulmonary gas embolism transiently increases exhaled nitric oxide (FENO), but it is not known whether solid emboli may alter FENO, and whether an intact endogenous NO synthesis has a beneficial effect in experimental solid pulmonary embolism. EXPERIMENTAL APPROACH: We used anaesthetised and ventilated rabbits in these experiments. To mimic PE, a single intravenous infusion of homogenized autologous skeletal muscle tissue (MPE) was given to rabbits with intact NO production (MPE of 60, 15, or 7.5 mg kg(-1); group 1) and to another group (group 2) with inhibited NO synthesis (L-NAME 30 mg kg(-1); MPE of 7.5, 15 or 30 mg kg(-1)). KEY
RESULTS: In group 1, after MPE, FENO increased rapidly and dose-dependently and FENO was still significantly elevated after 60 min with the two highest emboli doses. All these animals survived more than 60 min after embolization. In group 2, MPE of 7.5, 15 and 30 mg kg(-1), in combination with NO synthesis inhibition, resulted in 67%, 50% and 25% survival at 60 min respectively, representing a statistically significant decrease in survival. Cardiovascular and blood-gas changes after MPE were intensified by pre-treatment with NO synthesis inhibitor. CONCLUSIONS AND IMPLICATIONS: We conclude that solid PE causes a sustained, dose-dependent increase in FENO, giving FENO a diagnostic potential in PE. Furthermore, intact NO production appears critical for tolerance to acute PE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211456      PMCID: PMC2189723          DOI: 10.1038/sj.bjp.0707001

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Regulation of regional lung perfusion by nitric oxide.

Authors:  Danguole Rimeika; Sven Nyrén; N Peter Wiklund; Lotta Renström Koskela; Anders Tørring; Lars E Gustafsson; Stig A Larsson; Hans Jacobsson; Sten G E Lindahl; Claes U Wiklund
Journal:  Am J Respir Crit Care Med       Date:  2004-05-06       Impact factor: 21.405

2.  Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages.

Authors:  M Di Rosa; M Radomski; R Carnuccio; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

Review 3.  Hemodynamic and ventricular responses to pulmonary embolism.

Authors:  K M McIntyre; A A Sasahara
Journal:  Prog Cardiovasc Dis       Date:  1974 Nov-Dec       Impact factor: 8.194

4.  Selective pulmonary vasodilatory effect of ZSY-27 in dogs with pulmonary hypertension due to pulmonary embolism.

Authors:  K Tajimi; H Tanaka; T Kasai; K Kobayashi; A Okuaki
Journal:  Crit Care Med       Date:  1989-02       Impact factor: 7.598

5.  Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals.

Authors:  T Utsunomiya; M M Krausz; D Shepro; H B Hechtman
Journal:  Am J Physiol       Date:  1981-11

6.  Pulmonary embolism: high-frequency jet ventilation offers advantages over conventional mechanical ventilation.

Authors:  I P Murray; M S Mikhail; M J Banner; J H Modell
Journal:  Crit Care Med       Date:  1987-02       Impact factor: 7.598

7.  The effect of vasospasm on perfusion radionuclide imaging in experimental pulmonary embolism.

Authors:  D S Feigin; J J Bookstein; N P Alazraki
Journal:  Invest Radiol       Date:  1983 Sep-Oct       Impact factor: 6.016

8.  Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.

Authors:  H J Priebe
Journal:  Am J Physiol       Date:  1988-11

9.  Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung.

Authors:  P D Cherry; C N Gillis
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

10.  The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism.

Authors:  W C Reeves; L M Demers; M A Wood; S Skarlatos; G Copenhaver; L Whitesell; J R Luderer
Journal:  Prostaglandins Leukot Med       Date:  1983-05
View more
  3 in total

1.  Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes.

Authors:  Carlos A Dias; Evandro M Neto-Neves; Marcelo F Montenegro; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-02       Impact factor: 3.000

2.  Exhaled Nitric Oxide Is Useful in Symptomatic Radioactive Pneumonia: A Retrospective Study.

Authors:  Jiancheng Li; Xiaobin Fu; Jie Fu
Journal:  Mediators Inflamm       Date:  2017-09-24       Impact factor: 4.711

3.  Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.

Authors:  Kristofer F Nilsson; Lars E Gustafsson
Journal:  Pharmacol Res Perspect       Date:  2019-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.